{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T23:58:55Z","timestamp":1769558335250,"version":"3.49.0"},"reference-count":32,"publisher":"Tech Science Press","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2025]]},"DOI":"10.32604\/or.2025.061978","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T05:13:56Z","timestamp":1744002836000},"page":"1739-1755","source":"Crossref","is-referenced-by-count":2,"title":["IL1A: a novel prognostic biomarker and potential therapeutic target for renal clear cell carcinoma"],"prefix":"10.32604","volume":"33","author":[{"given":"JI","family":"ZENG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"XUETENG","family":"MENG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUAN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JUN","family":"LI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TAOTAO","family":"MA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CHENG","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17807","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12943-023-01911-x","article-title":"Evolution of cell therapy for renal cell carcinoma","volume":"23","author":"Wang","year":"2024","journal-title":"Mol Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrneph.2017.59","article-title":"Metabolic reprogramming in clear cell renal cell carcinoma","volume":"13","author":"Wettersten","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41585-022-00676-0","article-title":"Prognostic and predictive biomarkers for immunotherapy in advanced renal cell carcinoma","volume":"20","author":"Rosellini","year":"2023","journal-title":"Nat Rev Urol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: From biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.urolonc.2021.11.029","article-title":"IL-1A is associated with postoperative survival and immune contexture in clear cell renal cell carcinoma","volume":"40","author":"Jin","year":"2022","journal-title":"Urol Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"100789","DOI":"10.1016\/j.neo.2022.100789","article-title":"The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma","volume":"28","author":"Herremans","year":"2022","journal-title":"Neoplasia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.3390\/ijms21176009","article-title":"Roles of IL-1 in cancer: from tumor progression to resistance to targeted therapies","volume":"21","author":"Gelfo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and related cytokines in the regulation of inflammation and immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","article-title":"Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation","volume":"39","author":"Xiao","year":"2021","journal-title":"Cancer Cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","article-title":"Neutrophil profiling illuminates anti-tumor antigen-presenting potency","volume":"187","author":"Wu","year":"2024","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3946","DOI":"10.1016\/j.celrep.2018.05.082","article-title":"Neutrophils kill antibody-opsonized cancer cells by trogoptosis","volume":"23","author":"Matlung","year":"2018","journal-title":"Cell Rep"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"7814","DOI":"10.3390\/ijms21217814","article-title":"Investigation of the impact from IL-2, IL-7, and IL-15 on the growth and signaling of activated CD4+ T cells","volume":"21","author":"Coppola","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"5599660","DOI":"10.1155\/2023\/5599660","article-title":"Targeting neutrophil extracellular traps: a novel antitumor strategy","volume":"2023","author":"Zuo","year":"2023","journal-title":"J Immunol Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"735590","DOI":"10.3389\/fmed.2021.735590","article-title":"Optimization of BCG therapy targeting neutrophil extracellular traps, autophagy, and miRNAs in bladder cancer: implications for personalized medicine","volume":"8","author":"Mao","year":"2021","journal-title":"Front Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clim.2019.02.005","article-title":"BCG-induced formation of neutrophil extracellular traps play an important role in bladder cancer treatment","volume":"201","author":"Liu","year":"2019","journal-title":"Clin Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1172\/JCI77053","article-title":"Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer","volume":"124","author":"Eruslanov","year":"2014","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1200\/JCO.23.00172","article-title":"Bempegaldesleukin plus nivolumab in untreated advanced melanoma: the open-label, phase III PIVOT IO 001 trial results","volume":"41","author":"Diab","year":"2023","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.ccell.2019.05.005","article-title":"Targeting tumors with IL-10 prevents dendritic cell-mediated CD8+ T cell apoptosis","volume":"35","author":"Qiao","year":"2019","journal-title":"Cancer Cell"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"575597","DOI":"10.3389\/fimmu.2020.575597","article-title":"Localized interleukin-12 for cancer immunotherapy","volume":"15","author":"Nguyen","year":"2020","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"eaat9143","DOI":"10.1126\/scitranslmed.aat9143","article-title":"Durable anticancer immunity from intratumoral administration of IL-23, IL-36\u03b3, and OX40L mRNAs","volume":"11","author":"Hewitt","year":"2019","journal-title":"Sci Transl Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fimmu.2020.00176","article-title":"Adoptive cell therapy targeting neoantigens: a frontier for cancer research","volume":"11","author":"Wang","year":"2020","journal-title":"Front Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00292-022-01108-x","article-title":"IL-2\/IL-2R signaling and IL-2R\u03b1-targeted therapy in anaplastic large cell lymphoma","volume":"43","author":"Liang","year":"2022","journal-title":"Pathologie"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41467-020-20599-x","article-title":"Intratumoral IL-12 delivery empowers CAR-T cell immunotherapy in a pre-clinical model of glioblastoma","volume":"12","author":"Agliardi","year":"2021","journal-title":"Nat Commun"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nbt.4181","article-title":"Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery","volume":"36","author":"Tang","year":"2018","journal-title":"Nat Biotechnol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41587-019-0398-2","article-title":"Interleukin-23 engineering improves CAR T cell function in solid tumors","volume":"38","author":"Ma","year":"2020","journal-title":"Nat Biotechnol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"934343","DOI":"10.3389\/fimmu.2022.934343","article-title":"Regulatory CAR-T cells in autoimmune diseases: progress and current challenges","volume":"13","author":"Riet","year":"2022","journal-title":"Front Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e2213222120","DOI":"10.1073\/pnas.2213222120","article-title":"Cytokine conjugation to enhance T cell therapy","volume":"120","author":"Liu","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/s12967-024-05354-w","article-title":"IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6\/PI3K\/AKT axis","volume":"22","author":"Lu","year":"2024","journal-title":"J Transl Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/s41392-022-00872-9","article-title":"Targeting polarized phenotype of microglia via IL6\/JAK2\/STAT3 signaling to reduce NSCLC brain metastasis","volume":"7","author":"Jin","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/1758834016679942","article-title":"Nivolumab in renal cell carcinoma: Latest evidence and clinical potential","volume":"9","author":"Mazza","year":"2017","journal-title":"Ther Adv Med Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e0130980","DOI":"10.1371\/journal.pone.0130980","article-title":"Role of IL13RA2 in sunitinib resistance in clear cell renal cell carcinoma","volume":"10","author":"Shibasaki","year":"2015","journal-title":"PLoS One"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.techscience.cn\/files\/or\/2025\/TSP_OR-33-7\/OncolRes-33-07-61978\/OncolRes-33-61978.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T01:39:45Z","timestamp":1763343585000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v33n7\/62635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025]]},"published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2025.061978","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}